Popular on Amzeal
- Boost Board Gives Daily Visibility to Fundraising Campaigns Stuck at Zero - 117
- TBM Council Establishes TBM as The Business Operating System for AI
- AI Is Taking Action. Who Is Keeping the Record?
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Uk Financial Moonshot Token™ Robinhood-chain Goes Live On Tokpie Exchange Tomorrow, With Solana Side Of UKFLMS To Follow In Global Listing Expansion
- ACTIQO Launches on iOS to Help Families Manage Everything Around Kids' Activities
- Boom•Clap Spins Out of CanCanCan as an Independent Contextual Discovery Service
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
Similar on Amzeal
- Pom Malhotra Joins AutoMobility Advisors as Principal Consultant
- SecureMaine 2026 is Here -- Thursday October 8th!
- Metavalis Publishes 6 Pillar Framework Defining Artificial Synthetic Consciousness
- Google DeepMind Introduces SynthID Bio to Identify AI-Designed Proteins
- Mountzo Launches TV Mounting in Sacramento, Expanding Nationwide
- ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
- BJJ App mmaGPT Expands Academy Program to Support Jiu-Jitsu Instructors with AI Technique Coaching
- RAW Social Reports 1.9 Billion Audience as Platform Activity Expands
- Peptara Labs Is a Top Rated and Trusted Research Peptide Supplier With 3rd Party Lab COAs
- NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
Amzeal News/10624526
FAYETTEVILLE, Ark. - Amzeal -- Lineus Medical announces that SafeBreak® Vascular has been added to Alliant Purchasing's contract portfolio, expanding access to the breakaway IV technology across Alliant's extensive healthcare network. Alliant represents more than 280 hospitals and over 68,000 non-acute healthcare facilities across all 50 states. This agreement enables Alliant members to procure SafeBreak Vascular through streamlined contracting, supporting supply chain efficiency while bringing clinically proven IV complication reduction to a broader patient population.
SafeBreak Vascular is a breakaway device for IV lines clinically proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹
More on Amzeal News
"Joining the Alliant portfolio strengthens our ability to serve healthcare systems at scale," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "Group purchasing organizations(GPO) like Alliant play a critical role in helping hospitals evaluate and adopt innovative technologies while optimizing their supply chain operations. This contract provides a clear procurement pathway for Alliant members and supports our commercial growth as we continue expanding SafeBreak's presence in hospitals nationwide."
"The addition of SafeBreak to the Alliant GPO contract is a significant step forward in our mission to remove the pains associated with IV lines," said Vance Clement, CEO of Lineus Medical. "This agreement means that thousands of healthcare facilities across the country now have simplified access to SafeBreak."
The Alliant contract adds to Lineus Medical's growing presence in the group purchasing space, providing healthcare facilities with accessible options for adopting SafeBreak Vascular as part of their IV protocols.
More on Amzeal News
About Lineus Medical:
Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Alliant Purchasing:
Alliant Purchasing is a creative, value-focused, and progressive healthcare improvement partner that has been serving providers nationwide for over 35 years. With a commitment to operational and financial innovation, Alliant empowers members to navigate today's healthcare landscape through simplified supply chain strategies and impactful margin improvement opportunities. Leveraging more than $84 billion in buying power, Alliant supports over 280 hospitals and 68,000 provider locations. Learn more at www.alliantpurchasing.com.
References:
1. Data on file.
SafeBreak Vascular is a breakaway device for IV lines clinically proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹
More on Amzeal News
- Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
- Mountzo Launches TV Mounting in Sacramento, Expanding Nationwide
- ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
- BJJ App mmaGPT Expands Academy Program to Support Jiu-Jitsu Instructors with AI Technique Coaching
- CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
"Joining the Alliant portfolio strengthens our ability to serve healthcare systems at scale," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "Group purchasing organizations(GPO) like Alliant play a critical role in helping hospitals evaluate and adopt innovative technologies while optimizing their supply chain operations. This contract provides a clear procurement pathway for Alliant members and supports our commercial growth as we continue expanding SafeBreak's presence in hospitals nationwide."
"The addition of SafeBreak to the Alliant GPO contract is a significant step forward in our mission to remove the pains associated with IV lines," said Vance Clement, CEO of Lineus Medical. "This agreement means that thousands of healthcare facilities across the country now have simplified access to SafeBreak."
The Alliant contract adds to Lineus Medical's growing presence in the group purchasing space, providing healthcare facilities with accessible options for adopting SafeBreak Vascular as part of their IV protocols.
More on Amzeal News
- Crawfords Metal Detectors Stocks the Complete Minelab Detector Range
- American Garden Rose Selections™ Announces 2027 Winners
- RAW Social Reports 1.9 Billion Audience as Platform Activity Expands
- Peptara Labs Is a Top Rated and Trusted Research Peptide Supplier With 3rd Party Lab COAs
- Crossroads4Hope Launches Blood Cancer Resource Hub
About Lineus Medical:
Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Alliant Purchasing:
Alliant Purchasing is a creative, value-focused, and progressive healthcare improvement partner that has been serving providers nationwide for over 35 years. With a commitment to operational and financial innovation, Alliant empowers members to navigate today's healthcare landscape through simplified supply chain strategies and impactful margin improvement opportunities. Leveraging more than $84 billion in buying power, Alliant supports over 280 hospitals and 68,000 provider locations. Learn more at www.alliantpurchasing.com.
References:
1. Data on file.
Source: Lineus Medical
0 Comments
Latest on Amzeal News
- Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"
- Are We Already Entering the Age of Super Intelligence?
- L-Tron to attend GACP (Georgia Association of Chiefs of Police) Digital ID Reader Tech Expo Day
- 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
- Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
- SPOTAPOD Publishes Full Legal and Data Analysis of LinkedIn Engagement-Pod Activity
- Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
- Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
- HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
- AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
- $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
- LimeTime 3.7 Speaks Nine Languages and Joins Todoist as an Official Integration
- Qliko Is the New Wave of Social Media in 2026
- SidewalkKeep - An Intelligent Edge-AI Digital Co-Pilot for the Blind and Visually Impaired
- P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
- DBF Viewer 2000 v9.32 Adds New Control for Data Export
- Cloud SynApps and Partners to Explore the Future of Court Modernization in Webinar
- Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
- Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines



